| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.
BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 919.9K | - | - | |
| CEO | 497.0K | $34.30M | - | |
| CFO | 336.5K | $26.88M | - | |
| Other | 122.7K | $9.80M | - | |
| Dir | 120.8K | $10.15M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 24, 2019 | Bridgebio Pharma, Inc. | 10% Owner | Buy | 1,103,848 | $25.93 | $28,622,778.64 | +4.9% | |
| Dec 10, 2018 | Bridgebio Pharma LLC | 10% Owner | Sell | 40,653 | $13.33 | $542,063.25 | -0.2% | |
| Dec 7, 2018 | Bridgebio Pharma LLC | 10% Owner | Sell | 80,144 | $13.67 | $1,095,866.56 | -0.4% | |
| Dec 5, 2018 | Bridgebio Pharma LLC | 10% Owner | Buy | 2,853,848 | $14.92 | $42,589,910.48 | +14.5% | |
| Jun 22, 2018 | Bridgebio Pharma LLC | 10% Owner | Buy | 1,000,000 | $17.00 | $17,000,000.00 | +5.4% |